The US Food and Drug Administration (FDA) on Wednesday released final guidance for sponsors on when a standard release test and criteria may be used in lieu of extensive method development and ...
The US Food and Drug Administration (FDA) has published a new final guidance document on the criteria that sponsors of new and abbreviated drug applications (NDA/ANDA) should use to evaluate tablet ...
**Related video above: How concerned should you be about recalls. (NewsNation) — An Indian company is voluntarily recalling more than 11,000 bottles of blood pressure medication because of failed ...